ATE170745T1 - Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt - Google Patents

Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt

Info

Publication number
ATE170745T1
ATE170745T1 AT92907990T AT92907990T ATE170745T1 AT E170745 T1 ATE170745 T1 AT E170745T1 AT 92907990 T AT92907990 T AT 92907990T AT 92907990 T AT92907990 T AT 92907990T AT E170745 T1 ATE170745 T1 AT E170745T1
Authority
AT
Austria
Prior art keywords
adhesion
capsule
long
gastrointestinal tract
term effect
Prior art date
Application number
AT92907990T
Other languages
English (en)
Inventor
Kouichi Nakamichi
Shogo Izumi
Hiroshi Fukui
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE170745T1 publication Critical patent/ATE170745T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92907990T 1991-04-08 1992-04-06 Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt ATE170745T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10384691 1991-04-08

Publications (1)

Publication Number Publication Date
ATE170745T1 true ATE170745T1 (de) 1998-09-15

Family

ID=14364803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907990T ATE170745T1 (de) 1991-04-08 1992-04-06 Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt

Country Status (8)

Country Link
US (1) US5498422A (de)
EP (1) EP0580861B1 (de)
JP (1) JP2626248B2 (de)
AT (1) ATE170745T1 (de)
AU (1) AU1560692A (de)
CA (1) CA2107678A1 (de)
DE (1) DE69226950T2 (de)
WO (1) WO1992017166A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3168582B2 (ja) * 1993-12-10 2001-05-21 藤沢薬品工業株式会社 解熱鎮痛配合剤
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6010711A (en) * 1996-01-26 2000-01-04 University Of Rochester Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US20020119192A1 (en) * 2000-09-22 2002-08-29 Vishwanathan Narayanan Badri Controlled release formulations for oral administration
TR200402367T4 (tr) * 2000-10-12 2004-12-21 Boehringer Ingelheim Pharma Gmbh& Co.Kg Yeni tiotropyum içeren inhalasyon tozları
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
BR0312501A (pt) * 2002-07-10 2005-04-12 Warner Lambert Co Combinação de um inibidor alostérico ou metaloproteinase de matriz-13 com um inibidor de ciclooxigenase-2 diferente de celecoxib ou valdecoxib
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
CN101351196B (zh) * 2005-10-26 2013-07-03 班纳制药公司 作为胶囊填充物的基于亲脂性载体的双重控释基质系统
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
CN102438597A (zh) 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂
US20140228715A1 (en) * 2011-05-13 2014-08-14 The General Hospital Corporation Method and Apparatus for Delivering a Substance
SI2946774T1 (sl) * 2014-05-19 2020-07-31 Tillotts Pharma Ag Obložene kapsule s prirejenim sproščanjem
PL3188713T5 (pl) 2014-08-11 2024-07-29 Perora Gmbh Sposób wywoływania uczucia sytości
RS67855B1 (sr) 2014-08-11 2026-03-31 Woerwag Pharma Gmbh & Co Kg Formulacija koja sadrži čestice
CA2989510A1 (en) 2015-07-07 2017-01-12 Perora Gmbh Method of inducing satiety
CA2989508A1 (en) 2015-07-07 2017-01-12 Perora Gmbh Formulation comprising particles and a lipase inhibitor
JP6578459B1 (ja) * 2019-02-28 2019-09-18 アピ株式会社 ハードカプセル及びその製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002731A (en) * 1974-06-17 1977-01-11 Sterling Drug Inc. Diagnostic process using sodium tyropanoate
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
JPS587605B2 (ja) * 1977-09-08 1983-02-10 帝人株式会社 徐放性製剤およびその製造法
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
DE3400106A1 (de) * 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system

Also Published As

Publication number Publication date
EP0580861A1 (de) 1994-02-02
CA2107678A1 (en) 1992-10-09
AU1560692A (en) 1992-11-02
US5498422A (en) 1996-03-12
WO1992017166A1 (fr) 1992-10-15
DE69226950D1 (de) 1998-10-15
EP0580861A4 (de) 1994-03-21
DE69226950T2 (de) 1999-05-12
EP0580861B1 (de) 1998-09-09
JP2626248B2 (ja) 1997-07-02

Similar Documents

Publication Publication Date Title
ATE170745T1 (de) Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt
AU7992987A (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch
DE69803940D1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
FR2625217B1 (fr) Composition d'adhesif active sous l'effet de la pression a base de copolymere acrylique
EP0661045A4 (de) Hydrogelzubereitung mit verzögerter freisetzung.
ATE124255T1 (de) Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen.
IT1212714B (it) Cattiva motilita'procedimento e formulazioni gastrointestinale. farmaceutiche per controllare la
CA2399039A1 (en) Hyaluronic acid gel, method of its production and medical material containing it
EP0179023A3 (en) With micro-organisms degradable polypeptide, and its use for the progressive release of medicaments
ATE127019T1 (de) Antazida-zubereitung mit verlängerter magenverweilzeit.
CA2174325A1 (en) Non-antigenic branched polymer conjugates
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
CA2322579A1 (en) Gelling ophthalmic compositions containing xanthan gum
CA2235401A1 (en) Method for sterilizing medical devices utilizing a room temperature sterilant
NO944301L (no) Ikke-terapautisk mikrogranulært preparat
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
GB0111402D0 (en) Gelatin substitute
DE69603129D1 (de) Drehender Verbinder mit kugelförmigem Kontakt
IT1229205B (it) Composizioni farmaceutiche agenti in particolare sul cuore e sul cuore e sul sistema cardiovascolare e procedimento per la loro preparazione.
ES8700145A1 (es) Procedimiento para preparar tabletas que contienen un agente saporifero tal como aceite natural o sintetico y un polimero hidrofilo tal como polivinil pirrolidona.
IT1254898B (it) Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili
DE3881279D1 (de) Bildsensor vom typ "direkter kontakt".
IT9047759A0 (it) Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
IT8222049A0 (it) Dispositivo di deposito per cedere sostanze biologicamente attive al tratto digerente.
DE69617868D1 (de) Geschmacksmaskierte wässrige Lösungen enthaltend Ibuprofen und Menthol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties